AXIM Biotech CEO Appointed to American Pain Association Board of Advisors, Addresses American Opioid Abuse Epidemic
March 31, 2016 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 31, 2016 (GLOBE NEWSWIRE) -- Dr. George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM® Biotechnologies, Inc. (OTC:AXIM) was recently appointed to the American Pain...
AXIM Biotech Leads Cannabis Industry in Cannabinoid Research, Development and Intellectual Property; Tackles 15 Debilitating Conditions With No Known Cure
February 18, 2016 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Dr. George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM® Biotechnologies, Inc. (OTC:AXIM) shares the hemp innovator’s vision and...
AXIM Biotechnologies Expands Executive Team and Advisory Board With Finance and Pro Sports Leaders: Seth Yakatan and Marvin Washington
January 28, 2016 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Jan. 28, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies (OTC:AXIM) is proud to announce the following finance and community outreach-focused additions to the Company’s advisory...
Photo Release -- AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace to Advisory Board
August 26, 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Aug. 26, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is proud to announce the latest appointment to its Board of Advisors: Mr. Joe Grace. A proven business and marketing...
AXIM Biotech Explains Cannabis Chewing Gum Clinical Trials for Pain and Spasticity With MS, Plans to Enter General Pain Market
August 20, 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Aug. 20, 2015 (GLOBE NEWSWIRE) -- News of clinical trials on a new pharmaceutical cannabis chewing gum treatment option for pain and spasticity in Multiple Sclerosis (MS) patients by AXIM...
MJNA's Investment Company AXIM Biotech Announces Clinical Trial Launch of MedChew RX for Treatment of Pain and Spasticity in Multiple Sclerosis and Development of Pharmaceutical Cannabis Chewing Gum
August 13, 2015 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is an agricultural hemp industry innovator that sources, evaluates, invests in and acquires value-adding companies...
AXIM Biotech Announces Launch of Clinical Trials on MedChew RX(TM) and Development of Pharmaceutical-Grade Cannabis Chewing Gum
August 11, 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical,...
Medical Marijuana, Inc.'s CanChew -- Patented Cannabis Gum -- Featured in ABC, NBC, CBS, Yahoo! News and More From Chicago Cannabis Convention
July 30, 2015 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, July 30, 2015 (GLOBE NEWSWIRE) -- As Illinois implements the state's accessibility to medical cannabis, many patients, healthcare and legal professionals exchanged knowledge and resources...
AXIM Biotech Presents Patented Cannabinoid Delivery Methods at My Compassion's Chicago Cannabis Conference
July 29, 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, July 29, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) CEO George E. Anastassov, MD, DDS, MBA, proudly shared the Company's cannabinoid delivery methods – including...
Medical Marijuana, Inc.'s Video Statement on Investment Portfolio's Historic Accomplishments and Supporting the Science Behind Cannabis Legalization
July 15, 2015 10:15 ET
|
Medical Marijuana Inc
SAN DIEGO, July 15, 2015 (GLOBE NEWSWIRE) -- "Honestly, if you and I would have sat here two or three years ago, people would be saying, 'I would never invest in marijuana stocks,'" states Andrew...